PRESS OFFICEPress ReleasesLatest news
This Site All Sites
 
Latest news
 
  Latest news
May 08, 2008   Solvay to power its Bernburg (Germany) plant with secondary solid fuels
Energy generated from Refuse Derived Fuel Available in 2010
[EN]-[FR]-[NL]
   
April 25, 2008   SOLVAY PHARMACEUTICALS S.A. LAUNCHES FRIENDLY BID TO ACQUIRE INNOGENETICS
Building on a successful R&D co-operation
[EN]-[FR]-[NL]
   
March 31, 2008   Phase III studies of investigational Trilipix™ (SLV348/ABT-335), in combination with statins, meets primary endpoints on improving LDL, triglycerides and HDL
TriLipix™ in combination with statins improved all three key lipids and had reported safety consistent with TriLipix™ or statin monotherapies
[EN]-[FR]-[NL]
   
March 12, 2008   FDA approval of Abbott's SIMCOR® marks start of co-promotion with Solvay
FDA Decision Triggers Milestone Payment of USD 100 million by Solvay to Abbott
[EN]-[FR]-[NL]
   
March 06, 2008   Solvay finalized sale of polypropelene compounding activity to Lyondellbasell
Solvay announces today that it has finalized the sale of 100% of its subsidiary Solvay Engineered Polymers (SEP), a major supplier of polypropylene compounds, to LyondellBasell Industries.
[EN]-[FR]-[NL]
   
March 03, 2008   Fournier Laboratories Ireland Ltd and Laboratoires Fournier SA filed patent infringement actions against Teva in the USA
Fournier Laboratories asserts intellectual property of TriCor® (fenofibrate) 145mg NFE
[EN]-[FR]-[NL]
   
February 29, 2008   Solvay Pharmaceuticals S.A. acknowledges decision of Wyeth Pharmaceuticals to terminate the collaboration agreement on bifeprunox
Solvay Pharmaceuticals will evaluate all options for the future of the compound
[EN]-[FR]-[NL]
   
February 15, 2008   2007 Results
Record operating results for Solvay in 2007 of EUR 1.2 billion, up 9% from 2006
[EN]-[FR]-[NL]
   
February 01, 2008   Sale of Solvay’s Caprolactones business to Perstorp confirmed
Transaction Received European Commission Antitrust Clearance
[EN]-[FR]-[NL]
   
January 23, 2008   Fournier Laboratories Ireland Ltd was informed of anda filing for generic Tricor® in the USA
An Attempt to Seek Approval for a Generic Version of TriCor® 145mg NFE Tablets
[EN]-[FR]-[NL]
   
View all Press Releases
 
 12-05-2008 13:31 
93.38€ 1.35€
accueil
© Solvay S.A • Important information : Privacy policy  -  Disclaimer • If you have any comments, please contact the webmaster
Date of last update: 8/5/2008